Small bugs, big business: The economic power of the microbe

Biotechnology Advances

Volumn 18, Issue 6, 2000, Pages 499-514

  Demain, Arnold L ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Biotechnology; Economics; Primary metabolites; Secondary metabolites

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC PRODUCTION; BETA LACTAM; BIOSYNTHESIS; ERYTHROMYCIN; FINE CHEMICAL PRODUCTION; HYPOCHOLESTEROLEMIC AGENT; MICROORGANISM; SECONDARY METABOLITE; TETRACYCLINE;

AMINO ACIDS; ANTIBIOTICS; BIOSYNTHESIS; ECONOMIC AND SOCIAL EFFECTS; FERMENTATION; GENETIC ENGINEERING; ISOMERS; METABOLITES;

MICROBIAL BIOSYNTHESIS;

MICROBIOLOGY;

EID: 0034305155     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0734-9750(00)00049-5     Document Type: Article

References (73)

1. Effects of homoserine dehydrogenase deficiency on production of cytidine by mutants of Bacillus subtilis
2. Genetic and biochemical characterization of the birA gene and its product: Evidence for a direct role of biotin holoenzyme synthetase in repression of the biotin operon in Escherichia coli
3. Secondary metabolite biosynthesis: The first century
4. Pharmaceutical and biotech firms taking on drug-resistant microbes
5. Ivermectin: A potent new antiparasitic agent
6. The improving prospects for yield increase by genetic engineering in antibiotic-producing streptomycetes
7. Industrial enzyme technology
8. Emerging concepts of secondary metabolism in actinomycetes
9. Fungal secondary metabolism: Regulation and functions
10. New applications of microbial products
11. Production of nucleotides by micro-organisms
12. Riboflavin oversynthesis
13. A second branched-chain α-keto acid dehydrogenase gene cluster (bkdFGH) from Streptomyces avermitilis: Its relationship to avermectin biosynthesis and the construction of a bkdF mutant suitable for the production of novel antiparasitic avermectins
14. L-Glutamate and L-lysine: Traditional products with impetuous developments
15. Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductase
16. Production of a hybrid macrolide antibiotic in Streptomyces ambofaciens and Streptomyces lividans by introduction of a cloned carbomycin biosynthetic gene from Streptomyces thermotolerans
17. Cloning of the membrane-bound aldehyde dehydrogenase gene of Acetobacter polyoxogenes and improvement of acetic acid production by use of the cloned gene
18. Conversion of glucose to 2-keto-L-gulonate, an intermediate in L-ascorbate synthesis, by a recombinant strain of Erwinia citreus
19. Regulation of 6-phosphofructo-2-kinase from the citric-acid-accumulating fungus Aspergillus niger
20. Conversion of Lactococcus lactis from homolactic to homoalanine fermentation through metabolic engineering
21. Genetic modification of industrial microorganisms
22. Genetic engineering of ethanol production in Escherichia coli
23. Stimulatory effect of glycine betaine on L-lysine fermentation
24. Evolutionally guided enzyme design
25. Citric acid fermentation
26. Nucleotides, and related compounds
27. 12 biosynthesis in Pseudomonas denitrificans may be mediated by an increase in activity of δ-aminolaevulinic acid synthase
28. Enzyme catalysis: Cleaner, safer, energy efficient
29. U.S. biotech symposium focuses on bioprocessing
30. Further improvement of D-biotin production by a recombinant strain of Serratia marcescens
31. Setting course for prosperity
32. Multiple genetic modifications of the erythromycin polyketide synthase to produce a library of novel 'unnatural' natural products
33. Honoring the career and achievements of Monroe E. Wall
34. Increased inosine production by a Bacillus subtilis xanthine-requiring mutant derived by insertional inactivation of the IMP dehydrogenase gene
35. Cloning of the Bacillus subtilis IMP dehydrogenase gene and its application to increased production of guanosine
36. Microbial glucosidase inhibitors
37. L-Malic acid formation by immobilized Saccharomyces cerevisiae amplified for fumarase
38. Ethanol production in a continuous fermentation/membrane pervaporation system
39. Biotechnology in 1998 and beyond
40. Genentech develops recombinant technique for producing vitamin C
41. Recombinant human growth hormone
42. The fix is in: Cartels beware
43. Economics
44. Companies turn to biocatalysis
45. Biocatalysis at commercial scale: Myths and realities
46. Cloning of genes coding for L-sorbose and L-sorbosone dehydrogenases from Gluconobacter oxydans and microbial production of 2-keto-L-gulonate, a precursor of L-ascorbic acid, in a recombinant G. oxydans strain
47. Review of actinomycetes compounds 1990-1995
48. Biotin production under limiting growth conditions by Agrobacterium/Rhizobium HK4 transformed with a modified Escherichia coli bio operon
49. Use of recombinant DNA to improve production of cephalosporin C by Cephalosporium acremonium
50. Genetic control of metabolic functions in Rhizopus oryzae
51. 12
52. Zwittermicin A-producing strains of Bacillus cereus from diverse soils
53. Counting on chiral drugs
54. Industrial enzymes market
55. Trends in use of industrial bioprocessing enzymes for the 21st century
56. Biosynthesis of natural and hybrid polyketides by anthracycline-producing streptomycetes
57. Industrial antibiotics: Today and the future
58. Escherichia coli recombinant DNA technology
59. Biosynthesis of gibberellins in Gibberella fujikuroi: Biomolecular aspects
60. Low-molecular-weight enzyme inhibitors of microbial origin
61. Penicillin update: Industrial
62. Production of vitamins, coenzymes and related biochemicals by biotechnological processes
63. Bacterial biocatalysis: Stealing a page from nature's book
64. Polyether antibiotics: Versatile carboxylic acid lonophores produced by Streptomyces
65. Chemicals from biotechnology: Molecular plant genetics will challenge the chemical and the fermentation industry
66. The vancomycin group of antibiotics and the fight against resistant bacteria
67. Update on the restriction enzyme market for biotechnology industry in 1996
68. Study credits research advances and availability of financing
69. Biotechnology of succinic acid production and markets for derived industrial products